COMMUNICATIONS 23 e CONGRÈS GRRCN° in<strong>de</strong>x AMC : 15-05189 Improved local myocardial perfusion of chronic infarct myocardium <strong>de</strong>pends on the baseline level of residual perfusionbut not on the initial sites of transp<strong>la</strong>nted stem cells.N. TRAN, P. FRANKEN, J. NLOGA, S. POUSSIER, P. MAUREIRA, F. MASKALI, T. LAHOUTTE, G. KARCHER, J.-P. VILLEMOT, P.-Y. MARIE - Faculté <strong>de</strong> Mé<strong>de</strong>cine, 54500Vandœuvre-lès Nancy, FranceN° in<strong>de</strong>x AMC : 15-06200 La protéine PW1, un marqueur potentiel <strong>de</strong> cellules souches, induite dans un modèle murin d'infarctus cardiaque.A. PARLAKIAN, O. AGBULUT, G. MARAZZI, D. SASSOON - INSERM U787- UPMC, Paris, FranceN° in<strong>de</strong>x AMC : 15-07203 Therapeutic angiogenesis based on autologous transp<strong>la</strong>ntation of adipose tissue stroma cells in patients with chronic limb ischemia:preclinical results.V. PLANAT-BÉNARD, B. LÉOBON, J-A. PEYRAFITTE, P. BOURIN, J-S. SILVESTRE, P. CORDELIER, L. BUSCAIL, H. BOCCALON,L. PÉNICAUD, L. CASTEILLA - UMR 5018 CNRS/UPS, Toulouse, FranceN° in<strong>de</strong>x AMC : 15-08238 Cell therapy of ischemic syndromes: Novel approaches for improving survival of grafted cells.C. MIAS, MH. SÉGUÉLAS, E. TROUCHE, J. RONCALLI, P. BOURIN, A. PARINI, D. CUSSAC - INSERM, Toulouse, FranceN° in<strong>de</strong>x AMC : 15-09250 Adipose tissue cytokines stimu<strong>la</strong>te bone marrow mononuclear cell survival and proliferation, and enhance pro-angiogenic cell therapy.O. BLANC-BRUDE, J.-S. SILVESTRE, P. EREN, T.-G. EBRAHIMIAN, M. DURIEZ, B. COUSIN, V. PLANAT-BÉNARD,B. LÉVY, L. CASTEILLA, A. TEDGUi - Cardiovascu<strong>la</strong>r Research Center - INSERM U689, ParisN° in<strong>de</strong>x AMC : 15-<strong>10</strong>256 Culture of bone marrow-<strong>de</strong>rived endothelial progenitor cell on fibrin(ogen) stimu<strong>la</strong>tes their effects in pro-angiogenic cell therapy.O. BLANC-BRUDE, P. EREN, TG. EBRAHIMIAN, M. DURIEZ, B. LÉVY, J.S. SILVESTRE, A. TEDGUI - Cardiovascu<strong>la</strong>r Research Center INSERM U689, ParisN° in<strong>de</strong>x AMC : 15-11277 Hemodynamic improvement of a tissue engineered heart valve prosthesis by autologous mesenchymal stem cells.F. WAUTOT, A. VINCENTELLI, D. CORSEAUX, O. FOUQUET, S. MARÉCHAUX, F. JUTHIER, S. SUSEN, T. LETOURNEAU, B. JUDE, A. PRAT - INSERM ERI 9, Lille, FranceN° in<strong>de</strong>x AMC : 15-12279 Gingival fibrob<strong>la</strong>st protects e<strong>la</strong>stic fibers from <strong>de</strong>gradation by overexpressing TIMP-1 in an ex-vivo aorta mo<strong>de</strong>l.A. LAFONT, A. NAVEAU, B. FOURNIER, N. REINALD, E. DURAND, C. BRASSELET, P. BRUNEVAL, B. GOGLY - INSERM, Paris, FranceN° in<strong>de</strong>x AMC : 15-<strong>13</strong>281 Gingival fibrob<strong>la</strong>st inhibits MMP-7 secretion and expression in an ex-vivo aorta mo<strong>de</strong>l.B. GOGLY, B. FOURNIER, N. REINALD, A. NVEAU, E. DURAND, C. BRASSELET, A. LAFONT - INSERM, Paris, FranceN° in<strong>de</strong>x AMC : 15-14316 Phenotyping Murine Endothelial Progenitor Cells.E. BRAKENHIELM, O. BOYER, C. THUILLEZ, V. RICHARD - INSERM U644, Rouen, FranceN° in<strong>de</strong>x AMC : 15-15329 Gingival fibrob<strong>la</strong>sts inhibits artery MMP-1 and MMP-3 activities in coculture.A. NAVEAU, N. REINALD, B. FOURNIER, E. DURAND, A. LAFONT - INSERM EMI-0016, Paris, FranceN° in<strong>de</strong>x AMC : 15-16336 New pullu<strong>la</strong>n 3D matrices for in vitro and ex vivo transfection of rabbit vascu<strong>la</strong>r smooth muscle cells.A. SAN JUAN, H. HLAWATY, F. CHAUBET, D. LETOURNEUR, L.-J. FELDMAN - INSERM, Paris, FranceN° in<strong>de</strong>x AMC : 15-17338 Small interfering RNA for in vitro and ex vivo MMP-2 gene regu<strong>la</strong>tion in vascu<strong>la</strong>r smooth muscle cells.H. HLAWATY, A. SAN JUAN, M.-P. JACOB, R. VRANCKX, D. LETOURNEUR, L.-J. FELDMAN - INSERM U698, Paris, FranceN° in<strong>de</strong>x AMC : 15-18345 Fluorescent <strong>la</strong>belling of mesenchymal stem cells for monitoring cell survival after NOGA-gui<strong>de</strong>d injection in infarcted pig heart.J. RONCALLI, C. MIAS, D. CUSSAC, E. TROUCHE, P. BOURIN, M. ELBAZ, G. ESCOUROU, C. PIOT, M. GALINIER,J.-M. FAUVEL, A. PARINI - INSERM U589 et Fédération <strong>de</strong> <strong>Cardiologie</strong>, Toulouse, FranceN° in<strong>de</strong>x AMC : 15-19375 Doit on limiter l’angiop<strong>la</strong>stie à <strong>la</strong> phase aigue d’un IdM aux 12 premières heures ?Comparaison <strong>de</strong> <strong>la</strong> taille <strong>de</strong> l’infarctus reperfusé avant et après <strong>la</strong> douzième heure du début <strong>de</strong> <strong>la</strong> douleur.L. ERNANDE, S. MONZY, N. DUREL, A. AMONCHOT, H. MANSOUR, F. CACHIN, P. CHABROT, J. LIPIECKI, J. PONSONNAILLE - Clermont-Ferrand, France38
COMMUNICATIONS CLINIQUESN° in<strong>de</strong>x AMC : SCA 141 L'hyperglycémie découverte lors d'un syndrome coronaire aigu doit-elle être traitée systématiquement ?P. CASTELLANT, D. SALAUN, E. SONNET, P.-Y. PENNEC, M. GILARD, V. KERLAN, J. MANSOURATI - CHU Brest, Brest, FranceN° in<strong>de</strong>x AMC : SCA 270 Prise en charge pré-hospitalière <strong>de</strong>s syndromes coronaires aigus avec sus-déca<strong>la</strong>ge du segment ST à Marseille en 2005.L. NAÏT-SAÏDI, L. OLLIVIER, J. QUILICI, J. LEYRAL, P. PAULE, T. CUISSET, P. PES, J.-L. BONNET - CHU Timone, Marseille, FranceN° in<strong>de</strong>x AMC : SCA 395 Evaluation <strong>de</strong> <strong>la</strong> prise en charge <strong>de</strong> l’infarctus du myocar<strong>de</strong> à Marseille : registre EPECIM.L. NAIT-SAIDI *, J. LEYRAL **, T. CUISSET *, C. BUTIN **, J. QUILICI *, V. VIGUE **, J.-P. AUFFRAY **, J.-L. BONNET * -*Département <strong>de</strong> <strong>Cardiologie</strong> CHU Timone Marseille / **SAMU <strong>13</strong> MarseilleN° in<strong>de</strong>x AMC : SCA 497 Prognostic impact of chronic antip<strong>la</strong>telet therapy before AMI according to the mo<strong>de</strong> of reperfusion therapy:should thrombolysis be avoi<strong>de</strong>d in patients on antip<strong>la</strong>telet agents ?L. SABBAH, H. GORKA, A. OBLAK, C. BENSOUDA, J.-M. LABLANCHE, D. BLANCHARD, P. GUÉRET, G. HANANIA, L. VAUR, J.-P. CAMBOU - HEGP, Paris, FranceN° in<strong>de</strong>x AMC : SCA 51<strong>13</strong> Influence <strong>de</strong> l'éloignement <strong>de</strong>s centres <strong>de</strong> cardiologie interventionnelle sur <strong>la</strong> prise en charge <strong>de</strong>s syndromes coronaires aigusavec sus-déca<strong>la</strong>ge du segment ST.S. CHARPENTIER *, J.-P. CAMBOU *, V. BATAILLE *, J.-L. DUCASSÉ *, D. LAUQUE *, M. GALINIER *, C. BAIXAS *, D. CARRIÉ ** -*Comité Organisation ESTIM Midi-Pyrénées, CHU, Toulouse / **Pôle Cardio-Vascu<strong>la</strong>ire et Métabolique, CHU Rangueil, ToulouseN° in<strong>de</strong>x AMC : SCA 6128 Réponse au clopidogrel évaluée par <strong>la</strong> mesure <strong>de</strong> <strong>la</strong> phosphory<strong>la</strong>tion <strong>de</strong> <strong>la</strong> proteine VASP :valeur pronostique dans les syndromes coronaires aigus sans sus-déca<strong>la</strong>ge <strong>de</strong> ST.G. CAYLA, J.-C. MACIA, R. GERVASONI, H. RABESANDRATANA, J.-F. SCHVED, F. LECLERCQ - Hopital Arnaud <strong>de</strong> Villeneuve, Montpellier, FranceN° in<strong>de</strong>x AMC : SCA 7<strong>13</strong>7 Infarctus du myocar<strong>de</strong> au cours d’un traitement substitutif par méthadone.N. ANNABI, J.-L. GEORGES, M. AOUSJI, G. GALUSCAN, J. SCHWOB, B. LIVAREK - Centre Hospitalier <strong>de</strong> Versailles (Hôpital Mignot), Le Chesnay, FranceN° in<strong>de</strong>x AMC : SCA 8145 Augmentation du nombre d’épiso<strong>de</strong>s coronaires aigus après l’explosion <strong>de</strong> l’usine chimique AZF à Toulouse.M. COURNOT, V. BONGARD, C. FAURIE, S. CASSADOU, M. GIROUX, J. FERRIÈRES, J.-B. RUIDAVETS - INSERM U558, Département d'Epidémiologie, Toulouse, FranceN° in<strong>de</strong>x AMC : SCA 9178 Management and outcome of primary cardiogenic shock complicating acute myocardial infarction. Data from the RICO survey.J.-C. BEER, P. SICARD, J. RAVISY, M. ZELLER, M. JOLAK, M. VINCENT-MARTIN, L. ROCHETTE, Y. COTTIN - Service <strong>de</strong> <strong>Cardiologie</strong>, RICO, CHU Dijon, FranceN° in<strong>de</strong>x AMC : SCA <strong>10</strong>182 Re<strong>la</strong>tionship between erythropoietin levels and left ventricu<strong>la</strong>r function in acute myocardial infarction.P. LIM, D. MORRIS, S. MOUTEREAU, S. LORIC, T. HOVASSE, J.-L. MONIN, J. GAROT, J.-L. DUBOIS-RANDE, P. GUÉRET - Henri Mondor, Créteil, FranceN° in<strong>de</strong>x AMC : SCA 11183 Superiority of p<strong>la</strong>smatic fetuin-A Level (inhibitor of TNF) to CRP levels to predict 6 month mortality after acute myocardial infarction.P. LIM, J.-P. COLLET, S. MOUTEREAU, N. GUIGUI, J.-L. MONIN, T. HOVASSE, S. LORIC, G. MONTALESCOT, J.-L. DUBOIS-RANDÉ, P. GUÉRET - Henri-Mondor, Créteil, FranceN° in<strong>de</strong>x AMC : SCA 12Syndromes coronaires aigus (SCA)205 Prise en charge <strong>de</strong>s syndromes coronaires aigus au centre hospitalier <strong>de</strong> Vienne (38) entre 2002 et 2003 :apport <strong>de</strong> <strong>la</strong> mise en p<strong>la</strong>ce d’un protocole.N. PALEIRON *, C. EL K.HOURY (Correspondant) **, O. MATAS ** - *Hôpital Val <strong>de</strong> Grâce, Paris, France / **CH Lucien Hussel, Vienne, FranceN° in<strong>de</strong>x AMC : SCA <strong>13</strong><strong>10</strong>2 Benefice of a 600 mg loading dose of clopidogrel on p<strong>la</strong>telet aggregation and clinical outcomes in patientswith non-ST. segment elevation acute coronary syndrome un<strong>de</strong>rgoing coronary stenting.T. CUISSET, C. FRERE, J. QUILICI, P.-E. MORANGE, L. NAIT SAIDI, J. CARVAJAL, M. LAMBERT, M.-C. ALESSI, J.-L. BONNET - CHU Timone, Marseille, FranceN° in<strong>de</strong>x AMC : SCA 14<strong>13</strong>3 Urgence cardiologique en haute mer.U. VINSONNEAU, C. BOMBERT, C. VERGEZ-LARROUGET, R. DE KERSTRAT, A. BRONDEX, C. VANOYE, P. GODON, G. QUINIOU -Hôpital d'instruction <strong>de</strong>s Armées <strong>de</strong> Brest, FranceN° in<strong>de</strong>x AMC : SCA 1542 Prise en charge <strong>de</strong>s patients diabétiques <strong>de</strong> type II après un syndrome coronaire aigu.P. CASTELLANT, D. SALAUN, E. SONNET, P.-Y. PENNEC, M. GILARD, V. KERLAN, J. MANSOURATI - CHU Brest, Brest, France<strong>10</strong> 39